
| Salt Composition: | Ondansetron (4mg) |
| Manufacturer: | Medriff Lifesciences |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Nednor 4mg Tablet MD is an antiemetic medicine used to control nausea and vomiting due to certain medical conditions, surgery, cancer drug therapy, or radiotherapy. Nednor 4mg Tablet MD may be used alone or with other medications and can be taken with or without food. Your doctor will suggest the appropriate dose depending on what you are taking it for. The first dose is normally taken before the start of surgery, chemotherapy, or radiotherapy. After these treatments, take any further doses as prescribed by your doctor (normally only for a few days at most). Take it regularly at the same time(s) each day to get the most benefit. Be careful not to take too much. This medicine does not relieve other side effects associated with cancer treatments. Also, it has little effect on vomiting caused by motion sickness. The most common side effects of taking this medicine include headache, diarrhea, or constipation and feeling tired. These symptoms should disappear when you stop taking the medicine. However, if these side effects bother you or do not go away, your doctor may be able to suggest ways of preventing or reducing them. Before taking this medicine, tell your doctor if you have heart or liver problems or a blockage in your stomach or intestines. Also, tell your doctor about any other medicines you might be taking, especially medicines to treat epilepsy, heart problems, cancer, and depression. These may affect or be affected by this medicine. If you are pregnant or breastfeeding, ask for advice from your doctor.
Nednor 4mg Tablet MD is an antiemetic medication. It works by blocking the action of a chemical messenger (serotonin) in the brain that may cause nausea and vomiting during anti-cancer treatment (chemotherapy) or after surgery.
How quickly does Nednor 4mg Tablet MD start working?
Nednor 4mg Tablet MD typically begins to take effect within 30 minutes to 2 hours after administration. It rapidly dissolves into the bloodstream, allowing its effects to be observed shortly after ingestion.
What are the potential side effects of Nednor 4mg Tablet MD?
Common side effects of Nednor 4mg Tablet MD include constipation, diarrhea, fatigue, and headache. These reactions are usually mild and self-limiting, resolving on their own over time. However, if these symptoms persist or cause concern, it is essential to consult your doctor for guidance.
When should I take Nednor 4mg Tablet MD?
Nednor 4mg Tablet MD should be taken with a full glass of water, with or without food. It is crucial to follow the dosage and duration instructions provided by your doctor. Typically, the initial dose of Nednor 4mg Tablet MD is administered before surgery, chemotherapy, or radiation treatment.
Is Nednor 4mg Tablet MD a steroid?
No, Nednor 4mg Tablet MD is an antiemetic medication, not a steroid. It is a selective 5-HT3 receptor antagonist, primarily used for the prevention and treatment of nausea and vomiting associated with surgery or cancer chemotherapy.
Does Nednor 4mg Tablet MD work for seasickness?
Nednor 4mg Tablet MD is not effective for treating seasickness, as it has limited impact on nausea caused by motion sickness. If you experience seasickness, it is recommended to consult your doctor for alternative treatment options.
Take this medicine in the dose and duration as advised by your doctor. Do not handle the tablets with wet hands. Put it in your mouth but do not swallow it. Nednor 4mg Tablet MD may be taken with or without food but it is better to take it at a fixed time.
Alcohol
Consuming alcohol with Nednor 4mg Tablet MD does not cause any harmful side effects.
Breastfeed
Nednor 4mg Tablet MD is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnancy
Nednor 4mg Tablet MD is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.